Line workers in an aseptic formulation, fill, and finish operation may seem pretty far removed from the clinic, but in reality, contract manufacturing organizations (CMOs) have a tremendous impact on patient wellness. The more CMOs understand this influence, the better able they will be to ensure the needs of their ultimate customers—patients—are fully met.
Our pharmaceutical partners have assisted with the effort, coming to our facility to educate our employees about the disease their products treat, the agents' mechanisms of action, and the symptoms patients may experience. This knowledge helps keep the person waiting for treatment on top of the mind and it fosters a sense of pride and motivation to work harder and better. Thus, a patient-centric mindset can influence operational performance, batch-release times, exceptions for batches, and the overall performance of the facility.
Of course, considering patients and clinicians is good business. When pharmaceutical companies make it easier for clinicians to comply with regulations, it improves market share. When CMOs help reformulate or repackage a molecule to improve ease of administration, those efforts may extend the commercial lifecycle of the products.
But commerce cannot and should not be the ultimate objective. Producing high-quality therapeutics in a reliable fashion, and ensuring they meet the needs of patients, increases the likelihood that patients will get better, live longer, or manage a chronic disease more easily. If someone's life is better because of a therapeutic, then a day's work in the clinic, at a pharmaceutical company, and in a CMO was filled with purpose.
And, ultimately, that is what makes an organization successful.